Skip to main content
Premium Trial:

Request an Annual Quote

Barbara Alving to Leave NCRR

Barbara Alving, the director of the National Center for Research Resources at NIH, is resigning from her post effective at the end of September. Alving became acting director of the center in March 2005 and has been director since April 2007. Alving tells ScienceInsider that she is leaving because she has attained her "major goals," including the creation of the Clinical and Translational Science Awards. As of the first of October, the NCRR programs are supposed to be redistributed to other NIH institutes and centers to make way for the National Center for Advancing Translational Sciences. However, ScienceInsider points out that Congress isn't expected to have a 2012 budget ready by then, and a continuing resolution would have to specifically dismantle NCRR and establish NCATS. "I actually think that NCRR is going to continue on for an indefinite period of time," Alving says.

"To date, no one in the legislative branch has been publicly enthusiastic about Collins' proposed changes, which remain in limbo under a cloud of voiced concerns. Stay tuned," adds Writedit at Medical Writing, Editing & Grantsmanship.

NCRR Deputy Director Louise Ramm will be acting director of NCRR upon Alving's departure.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.